ROI appears to be on track, with four out of five seeing their gen AI investments paying off within three years.

Artificial intelligence is completely changing the way we go about our daily lives. Examples abound: Google Gemini’s diagnosis for your cold, your iPhone’s AI-powered photo editing, or ChatGPT’s ...

The conversation around AI is deafening. Headlines shout disruption, executives debate productivity, and experts argue endlessly about timelines. But in the middle of all that noise, Gen Z’s response ...

Clients are frequently asking some law firms for gen AI pointers. Law firms Stradley Ronon Stevens & Young and Honigman are finding ways to train their clients or internal staff. Stradley Ronon ...

Agents are the trendiest topic in AI today, and with good reason. AI agents act on their users’ behalf, autonomously handling tasks like making online purchases, building software, researching ...

Gen AI holds enormous promise to reshape e-discovery and beyond yet has yet to surpass TAR in efficiency or defensibility. Right now, legal teams should view TAR and Gen AI as complementary tools, ...

Key insight: Insurers are redefining liability through generative AI policy exclusions. What's at stake: Unchecked AI exposures could prompt regulatory penalties, class actions and concentrated losses ...

Where to use it, where not to, and why strategy still wins. by Bharat N. Anand and Andy Wu The questions about generative AI that we hear most often from business leaders include: When will gen AI ...

While 2025 did not have a song of the summer, it had the denim wars. American Eagle, Gap, Levi’s, Abercrombie and others poured millions into marketing investments and celebrity-driven campaigns, all ...

The shark from Jaws attacked without warning, showing how an apex predator exploits chaos to create lethal, devastating harm on its prey. Now, Forrester says, gen AI has become that predator in the ...

Generative AI is transforming pharma’s slowest lane —regulatory affairs — into a fast track for life-saving treatments. Bringing a new drug to market is one of the most expensive and time-consuming ...